logo
Volume 6, Issue 3 (2017)                   J Police Med 2017, 6(3) | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Hashemi J, Nazemi A. Effectiveness of Acceptance and Commitment Therapy (ACT) on Admission of Treatment Plan in Marijuana, Phencyclidine and Ketamine Abusers. J Police Med 2017; 6 (3)
URL: http://jpmed.ir/article-1-583-en.html
1- MA, Ardabil Police Command Office of Applied Research, Institute of Police Sciences & Social Studies, Ardabil, Iran
2- MA, Department of Psychology, Young Researchers & Elite Club, Ardabil Branch, Islamic Azad University, Ardabil, Iran
English Extended Abstract:   (2862 Views)

Aim: Drug abuse is one of the most important mental concerns and most harmful social damages in the present time. The purpose of this study was to investigate the effectiveness of acceptance and commitment therapy on admission of treatment plan in marijuana, phencyclidine and ketamine abusers.
Materials & Methods: This semi-experimental study with pretest-posttest design with control group was performed in 6 addiction treatment centers in Ardabil, Iran, in the fall of 2016. Using available sampling method, 40 samples from marijuana, phencyclidine and ketamine abusers were selected. The DUDIT questionnaire was used for data collection. Data analysis was performed using the ANCOVA covariance analysis in SPSS 21 software.
Findings: In the pre-test, the control and experimental groups had a mean of 107.60±13.02 and 102.05±18.80, respectively (p>0.05). These values were 101.60±17.16 and 140.04±25.55 in the post-test, respectively (p=0.001).
Conclusion: Acceptance and commitment therapy increases the admission of treatment plan in marijuana, phencyclidine and ketamine abusers.
 
 

Full-Text [PDF 351 kb]   (954 Downloads)    
Article Type: Original Research | Subject: Addiction & Substance Abuse
Received: 2017/01/1 | Accepted: 2017/05/17 | Published: 2017/09/13

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.